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SUMMARY: The health benefits of olive oil are well-known. In this study, the unsaponifiable fraction of extra 
virgin olive oil (Unsap) was investigated for reducing power capacity, ferric reducing antioxidant power, fer-
rous chelating activity and nitric oxide inhibition. The present study was also designed to evaluate the in vitro 
cytotoxic effect of the Unsap against human carcinoma cells. The anti-inflammatory potential of Unsap has 
been determined via the inhibition of Human Cyclooxygenases. The results showed that Unsap is efficient for 
ferric reducing antioxidant power and nitric oxide inhibition. Unsap has a selective effect as anti-inflammatory 
agent. The results showed moderate to good in vitro antitumor activities of Unsap against human liver, lung and 
pancreas cancer cells with IC50 ranging from 19.6 to 30.4 µg/mL and good selectivity index (≥ 2). In conclusion, 
Unsap represents a promising and safe antitumor and antioxidant material that supports the need for further 
investigation.
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RESUMEN: Actividades antioxidantes, antiinflamatorias y citotóxicas de la fracción insaponificable de aceite 
de oliva virgen extra. Los beneficios para la salud del aceite de oliva son bien conocidos. En este estudio, se 
investigó la fracción insaponificable del aceite de oliva virgen extra (Insap) para reducir el poder antioxidante 
férrico, la actividad quelante ferrosa y la inhibición del óxido nítrico. El presente estudio también fue diseñado 
para evaluar el efecto citotóxico in vitro del Insap contra las células de carcinoma humano. La potencialidad 
antiinflamatoria del Insap se ha determinado mediante la inhibición de las ciclooxigenasas humanas. Los resul-
tados mostraron que el Insap es eficiente para reducir el poder antioxidante férrico y la inhibición del óxido 
nítrico. El Insap tiene un efecto selectivo como agente antiinflamatorio. Los resultados mostraron actividades 
antitumorales in vitro del Insap de moderadas a buenas contra células de cáncer de hígado, pulmón y páncreas 
humano con una CI50 que varía de 19,6 a 30,4 µg/ml y por su buen índice de selectividad (≥2). En conclusión, 
el Insap contiene material antitumoral y antioxidante prometedor y seguro que será respaldado por investiga-
ciones adicionales.
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1. INTRODUCTION
Extra virgin olive oil (EVOO) is the highest 
quality olive oil obtained from the olive fruit by 
mechanical processes. According to the Codex 
(2015) classification, EVOO category has free 
acidity, fatty acid ethyl esters, peroxide value and 
absorbance at 270 nm, and not higher than 0.8%, 
35 mg/kg oil, 20 milliequivalents of  active oxy-
gen/kg oil and 0.22, respectively. In addition, it 
should be free of  odor and taste defects. It con-
sists of  a major fraction of  unsaturated fatty acids 
and the Unsap (1-2%) composed of  aliphatic and 
triterpenic alcohols, sterols, hydrocarbons and 
α-tocopherol (Servili et al., 2014). Squalene repre-
sents the major hydrocarbon in the unsaponifiable 
fraction of  olive oil (Cardeno et al., 2014).
The Unsap of EVOO as a natural product has 
anti-inflammatory and anticancer effects on human 
colon cancer in murine models (Cardeno et al., 
2013). Escrich et al., (2011) attributed the beneficial 
effect of EVOO on the progression of breast cancer 
to its oleic acid content and its minor compounds. 
Dietary EVOO’s Unsap prevented the damage in 
acute colitis and reduced pro-inflammatory pro-
tein expression to its basal levels in mice (Sánchez-
Fidalgo et al., 2013). The Unsap of virgin olive 
oil prevented the development and progression of 
neuroinflammation-related diseases in obese mice 
(Toscano et al., 2019). A diet rich in EVOO exerts 
its effect on breast cancer by reducing the level of 
DNA damage (Solanas et al., 2010). Several studies 
have confirmed that the consumption of olive oil is 
effective in the prevention and treatment of cardio-
vascular diseases, and obesity and reduces the risk 
of cancer, especially breast, lung and stomach can-
cer (Covas et al., 2009). Squalene has chemopreven-
tive activity against colon cancer (Rao et al., 1998). 
Smith et al., (1998) reported that a diet that contains 
olive oil or squalene could effectively inhibit lung 
tumorigenesis and decrease lung tumor multiplicity. 
Warleta et al., (2010) suggested that the squalene in 
virgin olive oils could be partially responsible for a 
lower incidence of breast cancer due to its protec-
tive activity against oxidative DNA damage in nor-
mal mammary cells. Liver cancer is one of the most 
widespread malignant diseases (Bray et al., 2018). 
A polyphenolic extract of EVOO reduced cell pro-
liferation and increased cell death of liver cancer 
cell lines (HepG-2, Huh7 and Hep3B) (De Stefanis 
et al., 2019). Olive oil phenols such as hydroxytyro-
sol and oleuropein are not Unsap materials (Boskou, 
2015). Although, squalene and γ-Tocopherol proved 
to have antioxidant and anticancer activities when 
applied as pure substances individually (Newmark, 
1997; Abraham et al., 2019), Cardeno et al., (2014) 
reported that there is a great lack of knowledge on 
the biological activity of the Unsap of EVOO. The 
combination of these active compounds may be 
useful for enhancing the effectiveness, eliminating 
the free radicals’ destructive effects or minimizing 
the doses needed for inhibiting the growth of can-
cer cells. Therefore, the novelty of this study is the 
evaluation of the combined effect of the constitu-
ents present in the Unsap of EVOO on scavenging 
radicals, reduction in COX-2 activity and selectivity 
against cancer cells compared to normal cells. 
2. MATERIALS AND METHODS
2.1. Materials 
EVOO was obtained from the Agriculture 
Research Center, Giza, Egypt. Ascorbic acid, butyl-
ated hydroxytoluene (BHT), MTT and trypan blue 
dye were purchased from Sigma (St. Louis, MO, 
USA). Fetal Bovine serum, DMEM, L-glutamine, 
gentamycin and 0.25% Trypsin-EDTA were pur-
chased from Lonza (Walkersville, USA). Cell lines 
were obtained from the VACSERA Tissue Culture 
Unit, the Holding Company for Biological Products 
and Vaccines, Egypt.
2.2. Extraction of the unsaponifiable matter
The saponification of EVOO (5g) and extrac-
tion of the unsaponifiable matter were carried out 
according to the IUPAC (1992) method. 
2.3. Antioxidant assays 
2.3.1. Ferric reducing antioxidant power (FRAP) 
The reducing power of  Unsap was evaluated 
using the method of  Oyaizu (1986). This method 
is based on the reduction in ferricyanide in rela-
tion to different concentrations of  Unsap (from 
3.9 to 2000 μg/mL, in a geometric sequence). The 
absorbance was measured at 700 nm against a 
blank using a spectrophotometer (Milton Roy, 
Spectronic 1201). BHT was used as reference stan-
dard. The reducing capacity percentage (%) was 
















Where, A0: absorbance of the control solution. As: 
sample absorbance.
2.3.2. Ferrous metal chelating activity
Different concentrations of the Unsap and refer-
ence standard (from 3.9 to 2000 μg/mL, in a geo-
metric sequence) were added to a solution of FeCl2 
(2 mM). The reaction was initiated by the addition 
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of ferrozine (5 mM) and the mixture was shaken 
vigorously and left to stand at room temperature for 
10 min. Then, the absorbance of the solution was 
measured at 562 nm using a Milton Roy (Spectronic 
1201) spectrophotometer according to Gülҫin et al., 
(2003). Decreasing absorbance in the metal chelat-
ing activity showed that metal ions were chelated 
before ferrozine bonding. The percentage of inhibi-
tion of ferrozine-Fe2+ complex formation was given 













Where, A0 is the absorbance value of the control (in 
the presence of ferrozine and Fe2+ ions), and A1 is 
the absorbance value in the presence of the tested 
sample or standard. BHT was used as a reference 
standard. 
2.3.3. Nitric oxide (NO) radical scavenging activity 
The NO radical scavenging activity of Unsap was 
determined according to the method of Marcocci 
et al., (1994) by using a sodium nitroprusside (SNP). 
NO radical generated from SNP reacted with oxy-
gen to produce nitrite ions, which were measured by 
the Greiss reagent. The concentrations of the tested 
Unsap ranged from 3.9 to 2000 μg/mL in a geomet-
ric sequence. The absorbance was measured at 546 
nm against the corresponding blank solution (with-
out SNP). Ascorbic acid was used as a reference 
standard. All the tests were performed in triplicate. 
The percent inhibition activity was calculated using 
















where, Acontrol is the absorbance of the control reac-
tion at 546 nm and Atest represents the absorbance of 
a test reaction at the same wavelength. Tested mate-
rial concentration providing 50% inhibition (IC50) 
was calculated from the graph by plotting inhibition 
percentage against concentration.
2.4. In-vitro anti-inflammatory activity 
(Cyclooxygenase inhibition assay)
The cyclooxygenase inhibition assay was car-
ried out according to Larsen et al., (1996). Different 
concentrations of the tested sample (from 7.8 to 
1000 μg/mL, in a geometric sequence) were pre-
incubated with the cyclooxygenase enzymes (COX-1 
and COX-2) at room temperature (25 °C) for 5 min 
in the presence of hematin. Phenol (500  μM), 
1-leuco-dichlorofluorescein (20 μM), arachidonic 
acid (50 μM) and hematin (1 μM) in 1 mL of 0.1 
M Tris-buffer (pH 8) were pre-mixed and added to 
the enzyme mixture. The absorbance was recorded 
within 15 seconds of the addition using a Milton Roy 
(Spectronic 1201) spectrophotometer at 502 nm. A 
blank was made without the addition of enzymes. 
Celecoxib was used as a standard. The IC50 value 
(μg/mL), which is the concentration of the Unsap or 
standard that inhibited 50% of each cyclooxygen-
ase, was calculated from the curve.
2.5. In vitro anti-cancer assay
2.5.1. Cell line propagation 
The cytotoxic effects of Unsap were estimated in 
vitro against human Breast (MCF-7), Lung (A-549), 
Pancreas (Panc-1), Hepatocellular (HepG-2) car-
cinoma cells and a normal human lung cell line 
(WI-38). The cells were propagated in Dulbecco’s 
modified Eagle’s medium (DMEM) supplemented 
with 10% heat-inactivated fetal bovine serum, 1% 
L-glutamine, and 50 µg/mL gentamycin. All cells 
were kept at 37 ºC in a humidified atmosphere with 
5% CO2. 
2.5.2. Cytotoxicity evaluation 
The cytotoxicity assay of Mosmann (1983) was 
performed as follows: the cells were seeded in 96-well 
plates at a cell concentration of 1×104 cells per well 
in 100 µL of growth medium. After 24 h of seeding, 
fresh medium containing different concentrations 
(from 3.9 to 500 μg/mL, in a geometric sequence) of 
the tested sample was added. The Microtiter plates 
were incubated at 37 ºC in a humidified incubator 
with 5% CO2 for a period of 24 h. Control cells 
were incubated without the tested sample. Then, 
the yield of viable cells was determined by a MTT 
colorimetric method. The absorbances of the plates 
were measured at a wavelength of 570 nm using a 
Microplate reader (SunRise, TECAN, Inc., USA). 
Treated samples were compared with the cell control 
in the absence of the tested compounds. Vinblastine 
sulfate was used as a reference anticancer drug. All 
experiments were carried out in triplicate. The per-
centage of viability was calculated as illustrated in 




















Where: ODt is the mean optical density of wells 
treated with the tested sample and ODc is the mean 
optical density of the untreated cells. The relation 
between surviving cells and drug concentration is 
plotted to get the survival curve of each tumor cell 
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line after treatment with the specified compound. 
The 50% inhibitory concentration (IC50) or the cell 
cytotoxic concentration (CC50) is the concentration 
required to cause toxic effects in 50% of intact cells. 
IC50 was estimated from the graphic plots of the 
dose response curve for each concentration using 
Graphpad Prism software (San Diego, CA. USA).
2.6. Statistical analysis 
The results are expressed as the mean values ± 
standard deviation (SD) of three experiments. The 
statistical analysis was carried out using Statistica 
software (StatSoft Inc., Tulsa, OK, USA). The 
Tuckey’s test was used at a significance level of 5%.
3. RESULTS AND DISCUSSION
Squalene represented the main component of 
the Unsap while β-sitosterol, and γ-tocopherol were 
found in minor quantities as reported previously 
(Cardeno et al., 2014; Galal et al., 2020). 
3.1. Antioxidant activity
The antioxidant activity of the Unsap was ana-
lyzed by different methods (FRAP, iron chelating 
activity and nitric oxide radical scavenging activity) 
to cover various ways of antioxidant protection and 
the results are illustrated in Figure1. 
Previous studies indicated that the antioxidant 
activity of some compounds is correlated with 
their reducing power. Figure 1a presents the reduc-
ing capacity of Fe3+→Fe2+ transformation in the 
presence of Unsap compared to the standard. The 
reducing power of the investigated Unsap and the 
positive standard BHT was concentration dependent 
and reached a plateau at concentrations higher than 
1000 μg/mL. The reducing power of 1000 μg/mL of 
the Unsap was not significantly different from that 
of BHT (p > 0.05) at 250 μg/mL. The IC50 value 
for Unsap (192.05 μg/mL) was higher than that of 
BHT (54.34 μg/mL), indicating lower activity of 
the Unsap. Abdallah et al., (2018) found that the 
polyphenol methanolic extract of olive oil samples, 
obtained from three Tunisian cultivars, had IC50 
values of FRAP ranging from 250 to 480 μg/mL. 
They ascribed this activity to the hydroxytyrosol and 
decarboxymethyl ligstroside aglycone in the poly-
phenol extract.
The generation of reactive oxygen species  can 
be avoided by the chelating of metal ions. Extracts 
with iron chelating activity are effective for the 
reduction of lipid peroxidation (Atere et al., 2018). 
Chelating agents disrupt the formation of the 
Ferrozine-Fe2+ complex and decrease the red color 
of the complex. The chelating effect of the Unsap 
on ferrous ions compared to BHT is illustrated in 
Figure1b. The chelating efficiency of 2000 μg/mL of 
Figure 1. Antioxidant activity of Unsap of olive oil 
compared to the standard as assessed by reducing capacity 
compared to butylated hydroxytoluene (BHT) (a), metal 
chelating activity compared to BHT (b), nitric oxide (NO) 
radical scavenging activity compared to ascorbic acid 
(c). The results are presented as average values of three 
replicates ± SD. Values with different letters indicate 
significant differences (p < 0.05) according to Tukey’s test.
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the Unsap was not significantly different from that 
of BHT (p > 0.05) at 500 μg/mL. The IC50 value of 
the Unsap for chelating activity was 306.73 µg/mL, 
which was higher than the positive standard BHT 
(IC50 = 50.20 µg/mL). 
Based on Figure 1c, the evaluation of nitric 
oxide radical (generated by sodium nitroprusside 
at physiological pH) scavenging activity of Unsap 
and ascorbic acid showed a similar trend. The nitric 
oxide radical scavenging activity of the Unsap was 
not significantly different from that of the ascorbic 
acid (p > 0.05) at all the investigated concentra-
tions. The IC50 value for Unsap (116.7 μg/mL) was 
lower than that of the ascorbic acid (176.5 μg/mL) 
indicating higher antioxidant activity. Franco et al., 
(2014) found that NO antiradical activity of the oils 
of seven Spanish olive varieties ranged from 29.8 to 
40.7% at 5.6 mg/mL of olive oil methanol solution. 
Based on the data obtained from this study, the 
tested olive oil Unsap exhibits free radical inhibitor 
or scavenger activity for NO radical thus acting as 
primary antioxidant which reacts with free radicals, 
and may limit free radical damage in the human 
body. 
3.2. Anti-inflammatory activity 
The Unsap was investigated for its efficiency 
to inhibit human cyclooxygenases (COX-1 and 
COX-2) compared with celecoxib as a standard 
drug. The results are shown in Figure 2. The COX 
enzymes were inhibited by the tested Unsap in a dose 
dependent manner. The investigated Unsap demon-
strated a weak potency towards COX-1 (inhibition 
did not exceed 37.25% at 1000 μg/mL), and moder-
ate potency towards COX-2 (IC50 = 412.20 μg/mL). 
The inhibitory effect of the Unsap at 1000 μg/mL on 
the activity of COX-2 was not significantly differ-
ent from that of celecoxib (p > 0.05) at 250 μg/mL. 
On the other hand, the IC50 value of the standard 
celecoxib on COX-1 and COX-2 was 400 μg/mL and 
84.05 μg/mL, respectively. 
The inhibition of nitric oxide (NO) and cyclo-
oxygenase-2 (COX-2) production is considered a 
promising approach for the treatment of various 
diseases, including inflammation and cancer as 
reported by Park et al., (2003). Therefore, the tested 
olive oil Unsap may be a useful anti-inflammatory 
and anticancer agent. 
3.3.  Cytotoxic activity of Unsap against cancer 
cell lines
The cytotoxicity of the Unsap was investigated 
on different cancer cell lines including MCF-7, 
A-549, Panc-1 and HepG-2 carcinoma cells, as 
shown in Figure 3. The inhibitory activity of Unsap 
against human lung fibroblast normal cell lines was 
also assayed. 
The Unsap exhibited a potential anticancer 
effect on the four tested cancer cell lines in a dose 
dependent manner. The inhibitory activities (IC50 
value) of the Unsap against MCF-7 (Figure 3a), 
A-549 (Figure 3b), Panc-1 (Figure 3c) and HepG-2 
(Figure 3d) carcinoma cells were 45.7 ± 2.1, 30.4 ± 
0.7, 19.6 ± 0.8 and 22.4 ± 0.4 µg/mL instead of 5.9 ± 
0.9, 24.6 ± 0.7, 2.89 ± 0.12 and 3.48 ± 0.22 µg/mL 
for the drug vinblastine sulfate, respectively.
With regard to MCF-7, the Unsap at 125 µg/mL 
showed significantly (p < 0.05) the same inhibition 
activity of 62.5 µg/mL of the vinblastine sulfate 
drug. Treating Panc-1 cancer cells with Unsap at 
62.5 µg/mL significantly induced (p < 0.05) the same 
inhibition effect as the standard drug at 15.6 µg/mL. 
The inhibition effect of the Unsap at 62.5 µg/mL 
on HepG-2 cancer cells was significantly (p < 0.05) 
Figure 2. Inhibition % of COX-1 and COX-2 by Unsap of 
olive oil compared with Celecoxib standard. The results are 
presented as average values of three replicates ± SD.  
Values with different letters indicate significant 
differences (p < 0.05) according to Tukey’s test.
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similar to that of the standard drug at 31.25 µg/mL. 
These results indicated that those carcinoma cells 
were less susceptible to the cytotoxic effect of the 
Unsap compared to vinblastine sulfate. It is inter-
esting to note that Unsap and vinblastine sulfate at 
the concentration of 62.5 µg/mL have significantly 
(p < 0.05) the same inhibition effect on A-549 lung 
cancer cells. The results clearly showed that Unsap 
at concentrations higher than 62.5 µg/mL was sig-
nificantly (p < 0.05) more efficient in the inhibition 
of A-549 cancer cells than vinblastine sulfate at the 
equivalent concentration.
Unsap exerts a low toxicity (CC50 = 59 ± 
3.9 µg/mL) on WI-38 human lung fibroblast nor-
mal cells (Figure 3e). However, the selective index 
(the ratio between IC50 value for normal fibro-
blast cells and IC50 value for cancer cells) towards 
HepG-2, A-549 and Panc-1 was 2.63, 1.94 and 3.01, 
respectively, indicating high selective toxicity (≥ 2) 
against those cancer cells as reported by Valderrama 
et al., (2016). Squalene has a chemopreventive effect 
against colon carcinogenesis (Rao et al., 1998). 
They attributed this effect to its inhibitory activity 
of HMG-CoA reductase and to suppressing the 
activation of oncogene proteins.
4. CONCLUSIONS
Unsap proved to have antioxidant activity and 
a selective cytotoxic effect against the A-549 can-
cer cell line. The data reveal that Unsap has anti-
cancer activity on lung cancer cells (A-549) which 
is comparable to that of  the drug vinblastine sul-
fate. These properties make Unsap a natural anti-
oxidant and a promising anti-tumor agent for 
new  pharmaceutical products to provide protec-
tion and treatment against the deleterious effects 
of  free radicals. 
Figure 3. Cytotoxicity effect of Unsap and Vinblastine sulfate concentrations (µg/mL) against MCF-7 human breast cancer cell 
line (a), A-549 human lung cancer cell line (b), Panc-1 human pancreas cancer cell line (c), HepG-2 human liver cancer cell line (d), 
WI-38 human lung fibroblast normal cells (e). The results are represented as average values of three replicates ± SD. Values with 
different letters indicate significant differences (p < 0.05) according to Tukey’s test.
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